Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 7,314,021 | 6,765,603 | 7,221,350 | 6,376,706 | 6,370,620 |
| Cost of Goods | 3,119,700 | 2,961,072 | 3,161,678 | 2,864,030 | 2,804,326 |
| Gross Profit | 4,194,321 | 3,804,531 | 4,059,673 | 3,512,676 | 3,566,294 |
| Operating Expenses | 2,788,436 | 2,656,762 | 2,542,349 | 2,586,152 | 2,380,256 |
| Operating Income | 1,406,585 | 1,147,841 | 1,518,002 | 926,554 | 1,186,364 |
| Interest Expense | 137,769 | 142,534 | 49,275 | 106,224 | 153,349 |
| Other Income | 367,502 | 155,419 | 14,199 | 73,089 | 219,623 |
| Pre-tax Income | 1,636,318 | 1,160,726 | 1,482,926 | 893,419 | 1,252,638 |
| Income Tax | 314,304 | 222,859 | 279,898 | 176,414 | 263,894 |
| Net Income Continuous | 1,322,014 | 937,867 | 1,203,028 | 717,005 | 988,744 |
| Net Income | $1,322,014 | $937,867 | $1,203,028 | $717,005 | $988,744 |
| EPS Basic Total Ops | 0.86 | 0.61 | 0.79 | 0.46 | 0.64 |
| EPS Basic Continuous Ops | 0.86 | 0.61 | 0.78 | 0.46 | 0.64 |
| EPS Diluted Total Ops | 0.85 | 0.60 | 0.77 | 0.46 | 0.63 |
| EPS Diluted Continuous Ops | 0.85 | 0.60 | 0.77 | 0.46 | 0.63 |
| EBITDA(a) | $1,872,445 | $1,599,695 | $2,001,193 | $1,430,323 | $1,621,865 |